Geron reports incentive grants pursuant to Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it has granted non-statutory stock options to purchase an aggregate of 500,220 shares of Geron common stock as an incentive to newly hired employees in connection with the commencement of their employment with the Company.

The stock options were granted on September 18, 2024 at an exercise price of $4.52 per share, which is the closing price of Geron's common stock on the date of grant. The stock options have a term of 10 years and vest over four years, with 12.5% ​​of the shares underlying the options vesting on the sixth anniversary of the respective employees' employment commencement date and the remaining shares vesting in equal installments of whole shares over the following 42 months, subject to continued employment with Geron until the applicable vesting dates. All stock options were granted as a material incentive for employment in accordance with Nasdaq Listing Rule 5635(c)(4) and are subject to the terms of the stock option agreements covering the grants and Geron's 2018 Inducement Award Plan, which was adopted on December 14, 2018 and provides for the grant of stock options to new employees.